Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The depths of PD-1 function within the tumor microenvironment beyond CD8+ T cells
Stephanie Laba, Grace Mallett, Shoba Amarnath
Seminars in Cancer Biology (2021) Vol. 86, pp. 1045-1055
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1113
Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
Te-An Lee, En-Yun Tsai, Shou-Hou Liu, et al.
Cancer Research (2024) Vol. 84, Iss. 6, pp. 800-807
Open Access | Times Cited: 18
Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 24
Receptor-Targeted Nanomedicine for Cancer Therapy
Arvee Prajapati, Shagun Rangra, Rashmi Patil, et al.
Receptors (2024) Vol. 3, Iss. 3, pp. 323-361
Open Access | Times Cited: 13
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Single‐Cell Landscape of Bronchoalveolar Lavage Fluid Identifies Specific Neutrophils during Septic Immunosuppression
Rong Shen, Yi Jiang, Guanglong Liu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Cooperation between inhibitory immune checkpoints of senescent cells with immunosuppressive network to promote immunosenescence and the aging process
Antero Salminen
Ageing Research Reviews (2025), pp. 102694-102694
Open Access | Times Cited: 1
“Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity
Lingjun Xiao, Louqian Zhang, Ciliang Guo, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 791-832
Open Access | Times Cited: 8
Tissue fibroblasts are versatile immune regulators: An evaluation of their impact on the aging process
Antero Salminen, Kai Kaarniranta, Anu Kauppinen
Ageing Research Reviews (2024) Vol. 97, pp. 102296-102296
Open Access | Times Cited: 7
Immunomodulatory Properties of Immune Checkpoint Inhibitors—More than Boosting T-Cell Responses?
Michael Kuske, Maximilian Haist, T. Jung, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1710-1710
Open Access | Times Cited: 24
Natural Killer Cells in the Malignant Niche of Multiple Myeloma
Ondrej Venglár, Julio Rodriguez Bagó, Benjamin Motais, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 23
The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases
Sruthi Vijaya Retnakumar, Camille Chauvin, Jagadeesh Bayry
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108399-108399
Open Access | Times Cited: 14
Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance
Mohd Nazzary Mamat Yusof, Kah Teik Chew, Nirmala Chandralega Kampan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15233-15233
Open Access | Times Cited: 12
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Comprehensive immunophenotyping reveals distinct tumor microenvironment alterations in anti-PD-1 sensitive and resistant syngeneic mouse model
Hiroyuki Inoue, Takayuki Hamasaki, Kazuhiko Inoue, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer
Parisa Shiri Aghbash, Nima Hemmat, Behzad Baradaran, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2022) Vol. 30, Iss. 3, pp. 99-116
Open Access | Times Cited: 18
PD‐1: A critical player and target for immune normalization
Xuening Liu, Alison Zhao, Su Xiao, et al.
Immunology (2024) Vol. 172, Iss. 2, pp. 181-197
Open Access | Times Cited: 3
Bariatric Surgery Induces Alterations in the Immune Profile of Peripheral Blood T Cells
Pedro Barbosa, Aryane Cruz Oliveira Pinho, André Lázaro, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 219-219
Open Access | Times Cited: 3
Identification of EGR4 as a prospective target for inhibiting tumor cell proliferation and a novel biomarker in colorectal cancer
Bangting Wang, Shijie Zhang, Haiyang Wang, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 871-883
Closed Access | Times Cited: 2
Identification and characterization of circulating and adipose tissue infiltrated CD20+ T cells from subjects with obesity that undergo bariatric surgery
Aryane Cruz Oliveira Pinho, Pedro Barbosa, André Lázaro, et al.
Immunology Letters (2024) Vol. 269, pp. 106911-106911
Open Access | Times Cited: 2
The Effects of Tamoxifen on Tolerogenic Cells in Cancer
Ros Akmal Mohd Idris, Ali Mussa, Suhana Ahmad, et al.
Biology (2022) Vol. 11, Iss. 8, pp. 1225-1225
Open Access | Times Cited: 10
Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity
Fei Chen, Yumei Fan, Xiaopeng Liu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 9
Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules
Nikita Abramenko, F.M.D. Vellieux, Kateřina Veselá, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
Yiru Long, Xiaolu Yu, Runqiu Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top